 | Arbutus Biopharma (NASDAQ:ABUS) Coverage Initiated at Robert W. Baird
www.americanbankingnews.com - February 19 at 5:12 PM |
| FY2019 Earnings Estimate for Arbutus Biopharma Corp Issued By Wedbush (NASDAQ:ABUS)
www.americanbankingnews.com - February 13 at 7:54 AM |
| Arbutus Biopharma Corp (NASDAQ:ABUS) to Post FY2024 Earnings of ($0.82) Per Share, Wedbush Forecasts
www.americanbankingnews.com - February 12 at 7:56 AM |
| Arbutus Biopharma Corp (NASDAQ:ABUS) Sees Large Growth in Short Interest
www.americanbankingnews.com - February 11 at 5:58 PM |
| B. Riley Reaffirms "Buy" Rating for Arbutus Biopharma (NASDAQ:ABUS)
www.americanbankingnews.com - February 11 at 11:17 AM |
 | Arbutus bails on AB-452; shares down 15% premarket
seekingalpha.com - February 10 at 1:33 PM |
 | Arbutus Announces Decision to Discontinue AB-452 and to Pursue Development of a Next Generation HBV Specific Oral RNA-Destabilizer
finance.yahoo.com - February 10 at 1:33 PM |
| Arbutus Biopharma Corp (NASDAQ:ABUS) Receives Consensus Rating of "Hold" from Analysts
www.americanbankingnews.com - February 10 at 8:53 AM |
| Arbutus Biopharma (NASDAQ:ABUS) Lifted to Outperform at JMP Securities
www.americanbankingnews.com - February 5 at 9:37 AM |
| Options Traders Expect Huge Moves in Arbutus Biopharma (ABUS) Stock
finance.yahoo.com - December 30 at 2:57 PM |
| Arbutus Biopharma Corp (ABUS): Hedge Funds In Wait-and-See Mode
finance.yahoo.com - December 19 at 5:52 PM |
| Arbutus Biopharma EPS misses by $1.26, misses on revenue
seekingalpha.com - November 6 at 12:49 PM |
| Arbutus Biopharma Corporation's (ABUS) CEO Bill Collier on Q3 2019 Results - Earnings Call Transcript
seekingalpha.com - November 6 at 12:49 PM |
| Arbutus Biopharma (ABUS) Reports Q3 Loss, Lags Revenue Estimates
finance.yahoo.com - November 6 at 12:49 PM |
| Arbutus Reports Third Quarter 2019 Financial Results and Provides Corporate Update
finance.yahoo.com - November 6 at 7:48 AM |
| We're A Little Worried About Arbutus Biopharma's (NASDAQ:ABUS) Cash Burn Rate
finance.yahoo.com - November 3 at 2:30 PM |
| We're A Little Worried About Arbutus Biopharma's (NASDAQ:ABUS) Cash Burn Rate
finance.yahoo.com - November 3 at 9:29 AM |
| Arbutus to Report Third Quarter 2019 Financial Results
finance.yahoo.com - October 30 at 12:26 PM |
| Will Arbutus Biopharma (ABUS) Report Negative Q3 Earnings? What You Should Know
finance.yahoo.com - October 30 at 12:26 PM |
| Bucks biopharm firm halts study of potential hepatitis B cure
finance.yahoo.com - October 10 at 6:28 PM |
| Arbutus Biopharma -28% after stopping development of hepatitis B drug
seekingalpha.com - October 4 at 4:08 PM |
| Arbutus -24.5% as it discontinues hepatitis treatment
seekingalpha.com - October 3 at 10:06 PM |
| Arbutus Announces Decision to Discontinue Development of AB-506, an Oral Capsid Inhibitor for the Treatment of Chronic Hepatitis B
finance.yahoo.com - October 3 at 5:05 PM |
| Did You Manage To Avoid Arbutus Biopharma's (NASDAQ:ABUS) Devastating 93% Share Price Drop?
finance.yahoo.com - September 19 at 10:43 AM |
| Did You Manage To Avoid Arbutus Biopharma's (NASDAQ:ABUS) Devastating 93% Share Price Drop?
finance.yahoo.com - September 19 at 10:43 AM |
| Arbutus on the hook for $5.8M in UBC patent case
seekingalpha.com - August 26 at 7:45 PM |
| Arbutus to Participate at Wedbush PacGrow Healthcare Conference
finance.yahoo.com - August 6 at 9:06 AM |
| Arbutus Biopharma Corporation (ABUS) CEO William Collier on Q2 2019 Results - Earnings Call Transcript
seekingalpha.com - August 5 at 11:40 PM |
| Arbutus Biopharma (ABUS) Reports Q2 Loss, Lags Revenue Estimates
finance.yahoo.com - August 5 at 11:40 PM |
| Arbutus Biopharma EPS misses by $0.08, misses on revenue
seekingalpha.com - August 5 at 9:07 AM |
| Arbutus Bio misses Q1 consensus
seekingalpha.com - August 5 at 9:07 AM |
| Arbutus Reports Second Quarter 2019 Financial Results and Provides Corporate Update
finance.yahoo.com - August 5 at 9:07 AM |
| Arbutus to Report Second Quarter 2019 Financial Results
finance.yahoo.com - July 29 at 11:19 AM |
| Will Arbutus Biopharma (ABUS) Report Negative Q2 Earnings? What You Should Know
finance.yahoo.com - July 26 at 8:30 AM |
| Arbutus up 3% after hours on encouraging data on HBV candidate AB-506
seekingalpha.com - July 15 at 6:59 PM |
| Arbutus Announces Preliminary Phase 1a/1b Clinical Trial Results for AB-506, an Oral Capsid Inhibitor in Development for People with Chronic Hepatitis B
finance.yahoo.com - July 15 at 6:59 PM |
| Here’s What Hedge Funds Think About Arbutus Biopharma Corp (ABUS)
finance.yahoo.com - July 4 at 6:56 PM |
| Arbutus sells portion of Onpattro royalties to Canadian pension plan
seekingalpha.com - July 2 at 6:40 PM |
| Arbutus receives clearance to initiate early-stage AB-729 trial; shares up 8% premarket
seekingalpha.com - June 20 at 7:51 PM |
| Arbutus receives regulatory clearance to initiate Phase 1a/1b Clinical Trial of AB-729
finance.yahoo.com - June 20 at 7:58 AM |
| New President & CEO at Arbutus Bio
seekingalpha.com - June 17 at 8:34 AM |
| Arbutus Appoints William Collier as Next President & CEO and Announces Retirement of Current President & CEO, Mark J. Murray Ph.D.
finance.yahoo.com - June 17 at 8:34 AM |
| Arbutus to Participate at JMP Securities Life Sciences Conference
finance.yahoo.com - June 13 at 12:58 PM |
| Arbutus Biopharma (ABUS) Presents At UBS Global Healthcare Conference - Slideshow
seekingalpha.com - May 23 at 7:26 PM |
| Is Arbutus Biopharma Corporation (NASDAQ:ABUS) Excessively Paying Its CEO?
finance.yahoo.com - May 22 at 7:18 PM |
| Arbutus to Present at Upcoming May 2019 Conferences
finance.yahoo.com - May 13 at 7:55 PM |
| Arbutus Biopharma Corporation (ABUS) CEO Mark Murray on Q1 2019 Results - Earnings Call Transcript
seekingalpha.com - May 7 at 8:24 AM |
 | Arbutus Reports First Quarter 2019 Financial Results and Provides Corporate Update
www.globenewswire.com - May 6 at 7:40 PM |
| Arbutus Biopharma (ABUS) Reports Q1 Loss, Misses Revenue Estimates
finance.yahoo.com - May 6 at 7:40 PM |
| Arbutus to Report First Quarter 2019 Financial Results
finance.yahoo.com - April 29 at 6:43 PM |
